表观遗传疗法:在治疗固体瘤方面,decitabine的研究进展
Chenlin Ye1, Nan Jiang1, Jing Zheng1
1Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Biochimica et biophysica acta. Reviews on cancer
|January 1, 2024
概括
德西塔在治疗固体瘤方面表现有前途,在治疗血液癌症方面取得了成功. 目前正在进行的研究正在探索其机制和对各种固体瘤类型的研究用途.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 癌症生物学 癌症生物学
背景情况:
- 德西塔已被批准用于治疗骨髓质疏松症候群 (MDS) 和急性骨髓性白血病 (AML).
- 美国食品和药物管理局 (FDA) 和欧洲药物管理局 (EMA) 的监管批准证实了其在血液恶性瘤中的有效性.
- 人们越来越感兴趣于decitabine在固体瘤治疗中的潜力.
研究的目的:
- 审查在固体瘤中使用decitabine的应用机制.
- 总结一下decitabine在固体瘤治疗中的当前状态.
- 为了探索decitabine用于固体恶性瘤的研究用途.
主要方法:
- 关于对固体瘤进行迪西他的临床前研究的审查.
- 对正在进行的临床试验的分析,涉及在固体癌症中使用decitabine.
- 检查在固体瘤中对德西他的拟议作用机制.
主要成果:
- 在固体瘤的临床前和临床研究中,低剂量德巴因表明了益处.
- 各种拟议的机制旨在解释desitabine在固体瘤中的有效性.
- 在固体瘤中使用decitabine的应用仍在研究中.
结论:
- 德西塔在血液癌症中的确定的作用推动了对固体瘤的探索.
- 需要进一步的研究,以充分理解和建立decitabine在固体瘤治疗中的作用.
- 德西塔是固体瘤的潜在治疗途径,需要继续进行研究.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K